Literature DB >> 30361453

Non-uraemic calciphylaxis (NUC) postliver transplantation.

Simona Frunza-Stefan1, Silpa Poola-Kella2, Kristi Silver1.   

Abstract

Calciphylaxis is a rare and life-threatening disease characterized by cutaneous arteriolar stenosis and vascular thrombosis leading to skin ischaemia and necrosis. While calciphylaxis occurs mostly in patients with end-stage renal disease, the disorder has been described in patients with normal renal function, namely non-uraemic calciphylaxis (NUC). A 41-year-old African-American woman presented with a painful ulcerative rash on her thighs and right buttock 2 months after undergoing an orthotopic liver transplantation. She underwent debridement of the lesions and an excisional biopsy of one of the lesions, which revealed calciphylaxis. She was treated with sodium thiosulfate, cinacalcet and hyperbaric oxygen with complete resolution of the lesions 4-5 months after presentation. While she was treated with a course of high-dose glucocorticoids after the transplant, she did not have other risk factors for calciphylaxis. NUC should be considered in the differential diagnosis of necrotic skin lesions in postliver transplant patients. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dermatology; liver disease

Mesh:

Year:  2018        PMID: 30361453      PMCID: PMC6203001          DOI: 10.1136/bcr-2018-226537

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  29 in total

1.  Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.

Authors:  Vincent M Brandenburg; Rafael Kramann; Hansjörg Rothe; Nadine Kaesler; Joanna Korbiel; Paula Specht; Sophia Schmitz; Thilo Krüger; Jürgen Floege; Markus Ketteler
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

2.  Quantifying a rare disease in administrative data: the example of calciphylaxis.

Authors:  Sagar U Nigwekar; Craig A Solid; Elizabeth Ankers; Rajeev Malhotra; William Eggert; Alexander Turchin; Ravi I Thadhani; Charles A Herzog
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

Review 3.  Calciphylaxis: diagnosis and clinical features.

Authors:  Matsuhiko Hayashi
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

Review 4.  Calcinosis cutis: part I. Diagnostic pathway.

Authors:  Nadine Reiter; Laila El-Shabrawi; Bernd Leinweber; Andrea Berghold; Elisabeth Aberer
Journal:  J Am Acad Dermatol       Date:  2011-07       Impact factor: 11.527

5.  Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series.

Authors:  A R Sood; L D Wazny; C B Raymond; K Leung; P Komenda; M Reslerova; M Verrelli; C Rigatto; M M Sood
Journal:  Clin Nephrol       Date:  2011-01       Impact factor: 0.975

Review 6.  Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review.

Authors:  Jennifer An; Bridget Devaney; Khai Yang Ooi; Sharon Ford; Geoff Frawley; Solomon Menahem
Journal:  Nephrology (Carlton)       Date:  2015-07       Impact factor: 2.506

7.  Thymus dependence of tapeworm (Hymenolepis diminuta) elimination from mice.

Authors:  D D Isaak; R H Jacobson; N D Reed
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

8.  Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Authors:  Sagar U Nigwekar; Steven M Brunelli; Debra Meade; Weiling Wang; Jeffrey Hymes; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

Review 9.  Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management.

Authors:  Preethi Yerram; Kunal Chaudhary
Journal:  Ochsner J       Date:  2014

Review 10.  Non Uremic Calciphylaxis Post Liver Transplantation: A Case Report and Literature Review of an Unusual Presentation of a Rare Disease.

Authors:  Swati Prabhakar; Ahmad M Tuffaha
Journal:  Am J Case Rep       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.